Mishaela R. Rubin

Endocrinology

180 Fort Washington Ave
New York, NY 10032

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway-trial.

Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway-trial.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: January 30, 2026

Bone material strength index: differences by race/ethnicity in Caribbean Hispanic, non-Hispanic White, and non-Hispanic Black older US adults.

Bone material strength index: differences by race/ethnicity in Caribbean Hispanic, non-Hispanic White, and non-Hispanic Black older US adults.

Journal: JBMR plus

Published: January 21, 2026

Sex- and Pubertal Stage-Specific Bone Microarchitecture and Strength in Adolescents With Type 1 Diabetes.

Sex- and Pubertal Stage-Specific Bone Microarchitecture and Strength in Adolescents With Type 1 Diabetes.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 07, 2025

Bone microarchitecture assessed by High-resolution peripheral quantitative computed tomography in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study.

Bone microarchitecture assessed by High-resolution peripheral quantitative computed tomography in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study.

Journal: JBMR plus

Published: September 22, 2025

Palopegteriparatide for Adults with Chronic Hypoparathyroidism: Skeletal Dynamics Through 3 yr of the Phase 2 paTH Forward Trial.

Palopegteriparatide for Adults with Chronic Hypoparathyroidism: Skeletal Dynamics Through 3 yr of the Phase 2 paTH Forward Trial.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: August 26, 2025

Early U.S. Real-World Treatment Patterns and Outcomes in Palopegteriparatide Treatment for Patients With Hypoparathyroidism.

Early U.S. Real-World Treatment Patterns and Outcomes in Palopegteriparatide Treatment for Patients With Hypoparathyroidism.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: June 12, 2025

Patient-reported outcomes in palopegteriparatide-treated adults with hypoparathyroidism: PaTH Forward trial extension.

Patient-reported outcomes in palopegteriparatide-treated adults with hypoparathyroidism: PaTH Forward trial extension.

Journal: The Journal of clinical endocrinology and metabolism

Published: May 27, 2025

Best practice recommendations for the diagnosis and management of hypoparathyroidism.

Best practice recommendations for the diagnosis and management of hypoparathyroidism.

Journal: Metabolism: clinical and experimental

Published: February 25, 2025

AGEs (Advanced Glycation End-products) in bone come of age.

AGEs (Advanced Glycation End-products) in bone come of age.

Journal: Bone

Published: October 23, 2024

mPatch: A Wearable Hydrogel Microneedle Patch for In Vivo Optical Sensing of Calcium.

mPatch: A Wearable Hydrogel Microneedle Patch for In Vivo Optical Sensing of Calcium.

Journal: Angewandte Chemie (International ed. in English)

Published: August 05, 2024

Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial.

Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial.

Journal: The Journal of clinical endocrinology and metabolism

Published: April 12, 2024

Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial.

Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial.

Journal: Advances in therapy

Published: December 30, 2023

Showing 1-12 of 88

Last Updated: 09/26/2026